Indications

Mesh Heading Maximum Phase Mesh ID Reference
Carcinoma, Basal Cell 2 D002280 ClinicalTrials
Prostatic Neoplasms 2 D011471 ClinicalTrials
Condylomata Acuminata 1 D003218 ClinicalTrials

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
25.0
Injury, poisoning and procedural complications
25.0
Reproductive system and breast disorders
20.0
Immune system disorders
10.0
Product issues
10.0
Musculoskeletal and connective tissue disorders
5.0
Skin and subcutaneous tissue disorders
5.0

Cross References

Resources Reference
CAS NUMBER 188265-33-0
ChEMBL CHEMBL1201723
FDA SRS T432289GYZ